Announcements Trials

Browse Landscape

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinal Cord Compression 1 Sarcoma 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Neoplasms, Unknown Primary 1 Melanoma 1 Gastrointestinal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adenocarcinoma 1 Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 31 Cisplatin 22 pembrolizumab 21 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 durvalumab 11 Mitomycin 10 enfortumab vedotin 9 avelumab 9 Cystoscopy 9 Nivolumab 8 Fluorouracil 8 Carboplatin 8 Radiation 7 Cystectomy 7 atezolizumab 5 Transurethral Resection of Bladder 5 Radiotherapy 5 Mitozytrex 5 Immunoglobulin G 5 Docetaxel 5 Disulfides 5 Biopsy 5 tremelimumab 4 sacituzumab govitecan 4 erdafitinib 4 dehydroftorafur 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 disitamab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Transurethral Resection of Prostate × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡